Borska L - Search Results

1

Non-Genomic Hallmarks of Aging-The Review.

Holmannova D, Borsky P, Parova H, Stverakova T, Vosmik M, Hruska L, Fiala Z, Borska L. Holmannova D, et al. Among authors: borska l. Int J Mol Sci. 2023 Oct 23;24(20):15468. doi: 10.3390/ijms242015468. Int J Mol Sci. 2023. PMID: 37895144 Free PMC article. Review.

2

Immunosuppressive effect of polycyclic aromatic hydrocarbons by induction of apoptosis of pre-B lymphocytes of bone marrow.

Novosad J, Fiala Z, Borská L, Krejsek J. Novosad J, et al. Among authors: borska l. Acta Medica (Hradec Kralove). 2002;45(4):123-8. Acta Medica (Hradec Kralove). 2002. PMID: 12587778 Review.

3

Health risk of occupational exposure in welding processes I. Genotoxic risk.

Borská L, Fiala Z, Smejkalová J, Tejral J. Borská L, et al. Acta Medica (Hradec Kralove). 2003;46(1):25-9. Acta Medica (Hradec Kralove). 2003. PMID: 12747536

4

Health risk of occupational exposure in welding processes II. Immunological effects.

Borská L, Fiala Z, Ctirad A, Krejsek J, Tejral J. Borská L, et al. Acta Medica (Hradec Kralove). 2003;46(1):31-5. Acta Medica (Hradec Kralove). 2003. PMID: 12747537

5

Possible genotoxic risk of combined exposure to pharmaceutical coal tar and UV-B radiation.

Borská L, Fiala Z, Smejkalová J, Hamáková K, Kremlácek J. Borská L, et al. Cent Eur J Public Health. 2004 Mar;12 Suppl:S14-5. Cent Eur J Public Health. 2004. PMID: 15141964

6

Cytogenetic and immunological changes after dermal exposure to polycyclic aromatic hydrocarbons and UV radiation.

Borská L, Fiala Z, Krejsek J, Hamáková K, Andrýs C, Smejkalová J, Vokurková D, Kremlácek J. Borská L, et al. Physiol Res. 2006;55(3):317-323. doi: 10.33549/physiolres.930787. Epub 2005 Aug 5. Physiol Res. 2006. PMID: 16083312 Free article. Clinical Trial.

7

Selected immunological changes in patients with Goeckerman's therapy TNF-alpha, sE-selectin, sP-selectin, sICAM-1 and IL-8.

Borská L, Fiala Z, Krejsek J, Andrýs C, Vokurková D, Hamáková K, Kremlácek J, Ettler K. Borská L, et al. Physiol Res. 2006;55(6):699-706. doi: 10.33549/physiolres.930928. Physiol Res. 2006. PMID: 16497101 Free article. Clinical Trial.

8

Genotoxic effect of Goeckerman regimen of psoriasis.

Fiala Z, Borska L, Pastorkova A, Kremlacek J, Cerna M, Smejkalova J, Hamakova K. Fiala Z, et al. Among authors: borska l. Arch Dermatol Res. 2006 Oct;298(5):243-51. doi: 10.1007/s00403-006-0691-z. Epub 2006 Aug 11. Arch Dermatol Res. 2006. PMID: 16902768 Clinical Trial.

9

Angiogenic activity in patients with psoriasis is significantly decreased by Goeckerman's therapy.

Andrys C, Borska L, Pohl D, Fiala Z, Hamakova K, Krejsek J. Andrys C, et al. Among authors: borska l. Arch Dermatol Res. 2007 Mar;298(10):479-83. doi: 10.1007/s00403-006-0723-8. Arch Dermatol Res. 2007. PMID: 17221216 Clinical Trial.

10

Immunologic changes in TNF-alpha, sE-selectin, sP-selectin, sICAM-1, and IL-8 in pediatric patients treated for psoriasis with the Goeckerman regimen.

Borska L, Fiala Z, Krejsek J, Andrys C, Vokurkova D, Hamakova K, Kremlacek J, Ettler K. Borska L, et al. Pediatr Dermatol. 2007 Nov-Dec;24(6):607-12. doi: 10.1111/j.1525-1470.2007.00548.x. Pediatr Dermatol. 2007. PMID: 18035981

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

65 results

Search Page

Filters